Martin Taylor-Rowan

Dr. Martin Taylor-Rowan is a Research Fellow in Health Economics and Health Technology Assessment at the University of Glasgow. He joined the institution in 2016 as a PhD student, transitioned to a post-doctoral researcher upon completing his doctorate in 2019, and now holds his current position. His work spans multiple departments within the Schools of Health and Wellbeing and Cardiovascular and Metabolic Science.

Research Focus: Dr. Taylor-Rowan specializes in psychometric evaluation of diagnostic tools for mood disorders and dementia, particularly for underserved populations unable to complete traditional assessments. His research also investigates modifiable dementia risk factors, with significant work on the impact of anticholinergic medications and the relationship between physical frailty and cognitive impairment. Methodologically, he employs systematic reviews, meta-analyses, psychometric validation, and both qualitative and quantitative approaches.

Publication Trends: His recent articles (2022-2025) predominantly focus on stroke outcomes, dementia screening tools, anticholinergic medication risks, and frailty assessment. Methodological themes include systematic reviews, meta-analyses, cohort studies, and clinical guideline development. Key recurring topics include validation of patient-reported outcome measures, deprescribing interventions, and novel approaches to functional assessment in neurological conditions.

Grants and Supervision:

• Production of Evidence Syntheses for NIHR (2023-2028)
• Frailty and post-stroke cognition: University of St Andrews (2021-2022)
• BGS Priority Setting Exercise: British Geriatric Society (2021-2023)
• Informant tools for dementia screening: NHS Greater Glasgow (2021-2022)
• COVID-19 in Care Homes literature scoping: Chief Scientific Adviser (2020)
• Supervision of Lucie Tvrdá's project on stroke recovery mechanisms (2021-2022)